相关实验视频

Updated: Sep 16, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

用放射治疗治疗小卵性非小细胞肺癌 - - 单中心经验

Artur Bandura¹, Paweł Tran Dinh², Anna Wrona¹

¹Department of Clinical Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.

Contemporary oncology (Poznan, Poland)

|July 7, 2025

概括

立体辐射疗法 (SRT) 对小胞性非小细胞肺癌 (OMD NSCLC) 有效. 患者的结果取决于转移的数量和性能状态,指导明智的治疗选择.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
肺部病理学肺部病理学

背景情况:

肺癌仍然是全球领先的恶性瘤.
寡母体扩散性疾病 (OMD) 是局部癌症和广泛癌症之间的中间阶段.
有效的局部疗法对于改善OMD非小细胞肺癌 (NSCLC) 的存活率至关重要.

研究的目的:

评估对OMD NSCLC的立体辐射疗法 (SRT) 的疗效.
确定影响OMD NSCLC患者SRT治疗生存的预后因素.

主要方法:

在2016-2022年期间,对127名OMD NSCLC患者接受SRT治疗的回顾性分析.
收集的数据包括患者人口统计,组织学,治疗细节,毒性和生存结果.
分析了对生存的预后因素.

主要成果:

大多数患者都能很好地容忍SRT.
同步OMD的无进展生存时间 (PFS) 中位数为11.1个月,甲时OMD为14.4个月.
生存的关键预后因素包括转移的数量和患者表现状况.

结论:

立体辐射疗法是管理OMD NSCLC的一个有价值的工具.
应该仔细考虑激进治疗,并保留给精选的患者.
预后因素,如转移数和表现状态,对于治疗决策至关重要.

关键词:

局部废除疗法局部废除疗法非小细胞肺癌是非小细胞肺癌.这是一种寡头性转移性疾病.辐射治疗疗法辐射治疗疗法

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...